| Common Brands | Doxil (pegylated liposomal doxorubicin), Caelyx (regional brand) |
|---|---|
|
Drug Class |
Anthracycline chemotherapy (liposomal formulation) |
|
Controlled Substance Classification |
Not a controlled medication |
|
Generic Status |
Lower-cost generic available |
|
Availability |
Prescription/oncology use; available in many countries through hospital/clinic pharmacies |
Doxorubicin liposomal (marketed under the brand name Doxil, among others) is a special formulation of doxorubicin, a chemotherapy drug used to treat various types of cancer, including ovarian cancer, breast cancer, Kaposi’s sarcoma, and multiple myeloma. The drug is encapsulated in tiny fat-like particles called liposomes, which helps to deliver the drug more effectively to cancer cells while minimizing damage to healthy tissues.
The liposomal version of doxorubicin differs from the traditional doxorubicin in that it is designed to increase the drug’s targeting to cancerous tissues and reduce side effects, particularly heart-related damage (a common problem with standard doxorubicin treatment). This formulation improves the drug’s pharmacokinetics, allowing it to remain in the bloodstream longer and be absorbed more efficiently by tumor cells.
Like traditional doxorubicin, doxorubicin liposomal works by interfering with the DNA inside cancer cells. It prevents these cells from replicating, leading to their death. Specifically, doxorubicin targets topoisomerase II, an enzyme required for DNA replication, which results in DNA damage and apoptosis (cell death).
The liposomal encapsulation has a few key advantages:
Although Doxil (doxorubicin liposomal) has reduced toxicity compared to traditional doxorubicin, it still has potential side effects. Some common and serious side effects include:
Before starting Doxorubicin liposomal, there are several important warnings to consider:
Doxorubicin liposomal can interact with several medications, and patients should inform their healthcare provider of all the drugs they are taking to avoid dangerous interactions. Some key interactions include:
The dosage of doxorubicin liposomal varies based on the type of cancer being treated, the patient’s condition, and how well they tolerate the drug. Doxorubicin liposomal is typically given via intravenous (IV) infusion in a clinical setting.
The specific dosing schedule and regimen can depend on the individual’s response and the type of cancer. Doxorubicin liposomal is often used in combination with other chemotherapy drugs, depending on the treatment protocol.
Doxorubicin liposomal is a prescription-only medication. It must be administered by a healthcare provider in a clinical setting, as it requires careful monitoring during infusion and over the course of treatment. Patients cannot self-administer the drug.
Seborrheic dermatitis is a widespread chronic inflammatory skin disorder that primarily affects the head, scalp, and upper trunk, which are areas rich in sebaceous glands. Despite not being a fatal illness, the chronic nature of the disorder and its frequent flare-ups can greatly lower the person’s standard of life. The goal of this thorough investigation
For a considerable time, both scientists and medical experts have been fascinated by the connection between the gastrointestinal tract and the brain. The gut-brain axis is a concept that has emerged from emerging research that highlights the deep relationship between both of these seemingly different organs. We will explore the elements, functions, and consequences associated
Food intolerances are becoming more widely acknowledged as serious health issues impacting people all over the world. In contrast to food allergies, which are immune system-related, food intolerances usually refer to the body’s incapacity to properly digest specific substances or dietary ingredients. This thorough review explores several kinds of food intolerances, such as fructose malabsorption,
